939 results
Coronary Microvascular Dysfunction: Why diagnosis in the Cathlab does matter
26 Jun 2020 – From PCR e-Course 2020
Watch this session to learn more about the prevalence of coronary microvascular dysfunction & angina, and to learn why diagnosis of coronary microvascular dysfunction is so important.
Merits of revascularisation and medical treatment in patients with chronic coronary syndromes
26 Jun 2020 – From PCR e-Course 2020
The main objectives when treating patients with chronic coronary syndromes are to reduce the risk of death and ischaemic events, and to improve the quality of life. Find out more on the role of medical treatment and revascularisation to achieve these goals.
This state-of-the-art lecture was originally...
Hot line on PCI: high bleeding risk and DAPT - part 1
26 Jun 2020 – From PCR e-Course 2020
Watch a series of Hot Lines on high bleeding risk and DAPT presented during the PCR e-Course 2020, followed by an analysis of the results and their impact on your practice: ARC-HBR, MODEL U-SES, Onyx ONE trials.
PCR e-Course 2020 Late-Breaking Trials – part 1
26 Jun 2020 – From PCR e-Course 2020
Watch a series of Late-Breaking Trials presented during the PCR e-Course 2020 and see how they might have an impact on your practice:
- Crossover results from the RADIANCE-HTN SOLO trial
- DynamX Bioadaptor, a novel « uncaging » platform
- Two-stent vs. provisional for bifurcation PCI: the DEFINITION II trial
CT guidance for coronary interventions - PCR e-Course 2020 Hot lines
26 Jun 2020 – From PCR e-Course 2020
Watch a series of Hot Lines on CT-guidance for PCI presented during the PCR e-Course 2020, followed by an analysis of the results and their impact on your practice: CT-FFR CHINA, CAST-FFR, CT-QFR vs. myocardial perfusion imaging, CT-CTO trial, CCTA for optimal fluoroscopic coronary projections.
PCR e-Course 2020 Late-Breaking Trials - part 2
26 Jun 2020 – From PCR e-Course 2020
Watch a series of Late-Breaking Trials presented during the PCR e-Course 2020 and see how they might have an impact on your practice:
- 2-year safety of revascularisation deferral based on iFR or FFR
- CABG and PCI in patients with CTO and multivessel disease
- Routine revascularisation vs. medical therapy
Abstracts on other coronary interventions - PCR e-Course 2020
25 Jun 2020 – From PCR e-Course 2020
View a selection of abstracts from PCR e-Course 2020 on the topic of Other coronary interventions:
- PCI with robotic assistance: the first 100 patients at Clinique Pasteur
- Safety and efficacy of sirolimus coated balloon in patients with CAD
Pharmacological treatment of SARS-CoV2: ongoing and planned clinical trials
25 Jun 2020 – From PCR e-Course 2020
In this video, Philippe Gabriel Steg provides an in-depth review of ongoing and planned clinical trials for the pharmacological treatment of SARS-CoV2 (COVID-19), as well as discussing some of the challenges linked to these trials, particularly the methodological challenges: enrollment window, ethical questions, which outcomes to...
Best real-world applications of Shockwave intravascular lithotripsy (IVL) in coronary calcium
25 Jun 2020 – From PCR e-Course 2020
Watch this session if you want to understand how intravascular lithotripsy works through real-world cases, to hear from global leading physicians about where intravascular lithotripsy fits into their clinical practice and to hear about some of the most prominent cases of coronary intravascular lithotripsy.
Target all comers 3-year results - Evaluation of Cobalt Chrome Rapamycin Drug Eluting Stent
25 Jun 2020 – From PCR e-Course 2020
Watch this session if you want to review the Firehawk family TES technology and early clinical outcomes in the treatment of atherosclerotic lesions, to gain the first sight of the 3-year results of the TARGET AC trial and to look into the Future Directions of Target...
